Poxviruses and apoptosis: A time to die

Current Opinion in Microbiology

Volumn 5, Issue 4, 2002, Pages 395-402

  Everett, Helen ^a   McFadden, Grant ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

APOPTOSIS; CELL DEATH; IMMUNE RESPONSE; NONHUMAN; POXVIRUS; PROTEIN TARGETING; REVIEW; VIRUS CELL INTERACTION; VIRUS INHIBITION;

POXVIRIDAE;

EID: 0036348872     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(02)00340-5     Document Type: Review

References (94)

1. The biochemistry of apoptosis
2. Apoptosis, lymphocytotoxicity and the containment of viral infections
3. Viral subversion of the immune system
4. Viruses and apoptosis
5. Immunology 102 at poxvirus U: Avoiding apoptosis
6. Immunomodulation by viruses: The myxoma virus story
7. How poxviruses oppose apoptosis
8. Control of apoptosis by poxviruses
9. Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells
10. Selective induction of apoptosis in antigen presenting cells in mice by Parapoxvirus ovis
11. Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction
12. Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by myxoma virus
13. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins
14. Host defence, viruses and apoptosis
15. Poxviruses: Interfering with interferon
16. The myxoma virus soluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species specific manner
17. Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits
18. Vaccinia, cowpox and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity
19. Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins
20. The vaccinia virus soluble interferon-gamma receptor is a homodimer
21. Effect of IFN-gamma receptor gene deletion on vaccinia virus virulence
22. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity
23. The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury
24. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity
25. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon α transmembrane signaling
26. The vaccinia virus soluble α/β interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN
27. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action
28. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms
29. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses
30. Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon
31. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells
32. Vaccinia virus E3L interferon resistance editing activity
33. Vaccinia virus blocks gamma interferon signal transduction: Viral VH1 phosphatase reverses Stat1 activation
34. Virus targeting of the tumor necrosis receptor superfamily
35. Tumor necrosis factor receptors encoded by poxviruses
36. Mxyoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFα but the dimer is a more potent TNF inhibitor
37. Mutational analysis of the ligand binding domain of M-T2 protein, the tumor necrosis factor receptor homologue of myxoma virus
38. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence
39. Expression of the myxoma virus tumor necrosis factor receptor homologue (T2) and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes
40. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the Type II TNF receptor
41. A third distinct tumor necrosis factor receptor of orthopoxviruses
42. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LTα
43. Analysis of host response modifiers ORF of ectromelia virus, the causative agent of mousepox
44. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses
45. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence
46. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
47. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis
48. Viral FLICE-inhibitory proteins (vFLIPs) prevent apoptosis induced by death receptors
49. Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein
50. Binding of FADD and Caspase-8 to molluscun contagiosum virus MC159 is not sufficient for its antiapoptotic function
51. MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-κB activation and apoptosis induced by PKR
52. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
53. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis
54. Target protease specificity of the viral serpin CrmA: Analysis of five caspases
55. Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA: An example of cross-class inhibition
56. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
57. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases
58. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A
59. Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A
60. Characterization of the ectromelia virus serpin, SPI-2
61. Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein
62. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product
63. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever
64. Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition
65. Crystallization and preliminary x-ray diffraction analysis of a recombinant cysteine-free mutant of crmA
66. Crystal structure of the apoptotic suppressor CrmA in its cleaved form
67. Inhibition of distant caspase homologues by natural caspase inhibitors
68. Serpin protein CrmA suppresses hypoxia-mediated apoptosis of ventricular myocytes
69. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells
70. Inhibition of Fas-mediated fuminant hepatitis in CrmA gene-transfected mice
71. The mode of death of pig kidney cells infected with cowpox virus is governed by the expression of the crmA gene
72. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β converting enzyme
73. SERP-2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus
74. Myxoma virus SERP-2 is a weak inhibitor of granzyme B and interleukin-1β-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells
75. Organelle-specific initiation of cell death pathways
76. Viral and bacterial proteins regulating apoptosis at the mitochondrial level
77. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: Novel mechanism for killing virus-infected cells
78. Viruses and apoptosis: Meddling with mitochondria
79. M11L: A novel mitochondria-localized protein of myxoma virus that blocks apoptosis in infected leukocytes
80. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor
81. Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore
82. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus
83. The genome of fowlpox virus
84. Ectromelia virus virulence factor p28 acts upstream of caspse-3 in response to UV light-induced apoptosis
85. Shope fibroma virus RING finger protein N1R binds DNA and inhibits apoptosis
86. Apoptosis regulators from DNA viruses
87. Heat shock response to vaccinia virus infection
88. Heat-shock proteins as death determinants
89. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes
90. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis
91. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits
92. Distinct domains of M-T2, the myxoma virus TNF receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition
93. Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells
94. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion